Valeant Pharmaceuticals International Inc.

Executive 1Mr. J. Michael Pearson, Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
Executive 2Dr. Pavel Mirovsky, President; Region Officer | Vice-Chairman; Division Officer
Earnings Per Share Growth (%)-88%
Cost of Goods Sold (US$ Millions)$2,255
Current Liabilities (US$ Millions)$2,731
Total Assets (US$ Millions)$4,193
Long Term Debt (Millions)$15,254
Return on Equity17.43%
Revenue (US$ Millions)$8,264
Total Company Assets$26,353
Revenue Growth (%)43.22%
Net Income (US$ Millions)$912
Earnings Per Share (US$)$2.67
Total Equity (US$ Millions)$5,435
Profit Margin (%)11.04%
Debt To Equity Ratio (%)2.81%
Inventories (Millions)$951